LBF20309EO01: Difference between revisions
No edit summary |
No edit summary |
(No difference)
|
Revision as of 14:00, 19 February 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | DFA8113 |
LipidMaps | - |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20309EO01 |
(+-) 14 (15) -epoxy-5Z,8Z,11Z-eicosatrienoic acid | |
---|---|
Structural Information | |
(+-) 14 (15) -epoxy-5Z,8Z,11Z-eicosatrienoic acid | |
| |
(±)14(15)-EpETrE | |
Formula | C20H32O3 |
Exact Mass | 320.23514489 |
Average Mass | 320.46628 |
SMILES | C(CCC(O1)C1CC=CCC=CCC=CCCCC(O)=O)CC |
Physicochemical Information | |
(±)14(15)-EpETrE is biosynthesized in rat and rabbit liver microsomes by cytochrome P450 Oliw_EH et al. Chacos_N et al.. | |
Dramatic increases in urinary (±)14,15-DiHETrE, a (±)14(15)-EpETrE metabolite, have been documented by GC/MS in pregnancy induced hypertension Catella_F et al.. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|